Sasayama’s Weblog


2009/05/21 Thursday

¾ÜÀâ-1957ǯ°ÊÁ°À¸¤Þ¤ì¿Í´Ö¤Ë¤Ï¡¢¿··¿¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¤ËÂФ¹¤ëÌȱ֤ò¤â¤Ä¤È¤ÎÀâ

Filed under: ̤ʬÎà — ´ÉÍý¿Í @ 19:42:07

2009ǯ5·î21Æü
¡¡
nullº£²ó¤Î¿··¿¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¤Ë¤Ï¡¢Ï·¿ÍÁؤ˴µ¼Ô¤¬¾¯¤Ê¤¤¤³¤È¤«¤é¡¢Ï·¿ÍÁؤˤϡ¢²¿¤é¤«¤ÎÌȱÖÂΤ¬¤¢¤ë¤Î¤Ç¤Ï¤Ê¤¤¤«¤È¤Î²±Â¬¤¬¡¢°ÊÁ°¤«¤é¤¢¤Ã¤¿¡£

»ä¤Î¤³¤Î¥Ö¥í¥°µ­»ö
¡Ö1968ǯ¤ÎH3N2¤Î¹á¹Á¥«¥¼¡¦¥Ñ¥ó¥Ç¥ß¥Ã¥¯¤¬¡¢¤½¤ÎÅö»þ¤Î¿Í´Ö¤Ë¡¢H1N1¹³ÂΤòÍ¿¤¨¤Æ¤¤¤ë¡¢¤È¤Î¸«Êý¡×
¤Ê¤É¤Ç¤â¤³¤ì¤Ë¤Ä¤¤¤Æ¤Î½ôÀâ¤ò¾Ò²ð¤·¤Æ¤­¤¿¡£

¤³¤³¤Ë¤­¤Æ¡¢ºòÆü¤ÎCDC¤Î¥×¥ì¥¹¡¦¥Ö¥ê¡¼¥Õ¥£¥ó¥°¤Ç¡¢CDC¤Î¥¤¥ó¥Õ¥ë¥¨¥ó¥¶ÉôÉûÉôĹ¤Î¥À¥Ë¥¨¥ë¡¦¥¸¥ã¡¼¥Ë¥¬¥ó(Daniel Jernigan)Çî»Î¤¬¡¢ WebMD¤ÎDaniel DeNoon»á¤Ê¤É¤Î¼ÁÌä¤ËÅú¤¨¤ë·Á¤Ç¡¢¼¡¤Î¤è¤¦¤ÊÀâ¤òŸ³«¤·¡¢ÏÃÂê¤Ë¤Ê¤Ã¤Æ¤¤¤ë¡£

»²¹Í
¡ÖPress Briefing Transcripts
CDC Telebriefing on Investigation of Human Cases of H1N1 Flu
¡×

¥ª¡¼¥Ç¥£¥ª¤Ç¤Îµ­¼Ô²ñ¸«¤ÎÌÏÍͤϤ³¤Á¤é¤ò¥¯¥ê¥Ã¥¯(MP3¥Õ¥¡¥¤¥ë)

¤Þ¤º¡¢WebMD¤ÎDaniel DeNoon»á¤Ï¡¢¼¡¤Î¤è¤¦¤Ê¼ÁÌä¤ò¤·¤¿¡£

¡ÖWHO¤ÎÀïά¥¢¥É¥Ð¥¤¥¶¥ê¡¼¡¦¥°¥ë¡¼¥×¡¬¤¬¡¢²áÆü¡¢Ï·¿ÍÁؤˤϡ¢H1N1¤ËÂФ¹¤ë¸òºµÌȱ֤¬¤¢¤ë¤¿¤á¤Ë¡¢·ìÀ¶Ãæ¤ËÃæϹ³ÂΤηÁÀ®¤ò¤·¤á¤·¤Æ¤¤¤ë¤È¤ÎÊó¹ð½ñ¤¬½Ð¤¿¤¬¡¢»ä¤É¤â¤Ï¡¢¤½¤Î¤³¤È¤¬´ûÀ®¤Î»ö¼Â¤Ç¤¢¤ë¤«¤É¤¦¤«¡¢¤ï¤«¤ê¤Þ¤»¤ó¡£
¤½¤ì¤¬ËÜÅö¤«¤É¤¦¤«¤Ë¤Ä¤¤¤Æ¥³¥á¥ó¥È¤·¤¤¤¿¤À:¤Þ¤»¤ó¤«?¡×
(Ãí-¤³¤³¤Ç¤¤¤¦WHOÀïά¥¢¥É¥Ð¥¤¥¶¥ê¡¼¡¦¥°¥ë¡¼¥×¤ÎÊó¹ð½ñ¤È¤Ï²¼µ­¤Î¤³¤È¤ò¸À¤Ã¤Æ¤¤¤Þ¤¹¡£
¡ÖRecommendations of the Strategic Advisory Group of Experts (SAGE) on Influenza A (H1N1) vaccines¡×
PDFÈǤϡ¢¤³¤Á¤é)

¤³¤ì¤ËÂФ·¤Æ¥À¥Ë¥¨¥ë¡¦¥¸¥ã¡¼¥Ë¥¬¥ó(Daniel Jernigan)Çî»Î¤Ï¡¢¼¡¤Î¤è¤¦¤Ë¤³¤¿¤¨¤¿¡£

¡Ö¤ª¤½¤é¤¯¡¢¤½¤Î¾ðÊó¤Ï¡¢º£Æü¤Î¸á¸å¤«ÌÀÆü¤ËMMWR(Morbidity and Mortality Weekly Report )¤«¤é¤Ç¤ë¥ì¥Ý¡¼¥È¤Ë´ð¤Å¤¯¤â¤Î¤Ê¤Î¤Ç¤·¤ç¤¦¡£
¸½»þÅÀ¤Ç¥³¥á¥ó¥È¤¹¤ë¤È¤¹¤ì¤Ð¡¢¤ï¤ì¤ï¤ì¤¬¡¢¤³¤ì¤Þ¤ÇÆÀ¤¿¡¢·ìÀ¶³Ø¾å¤Î¸¦µæ¤ä´µ¼Ô¤«¤é¤Î·ì±Õ¤«¤é¤¤¤¨¤ë¤³¤È¤Ï¡¢1957ǯ°ÊÁ°¤Ëº£²ó¤ÎH1N1¤ÈƱ¤¸¤è¤¦¤Ê¥¦¥¤¥ë¥¹¤ËÇøϪ¤µ¤ì¤Æ¤¤¤¿¤È¤¤¤¦¤³¤È¡¢¤½¤·¤Æ¡¢¤½¤Î¤³¤È¤¬¡¢º£²ó¤ÎH1N1¥¦¥¤¥ë¥¹¤ËÂФ·¤Æ¡¢¤¢¤ë¿Í¤ËÂФ·¤ÆÌȱÖÈ¿±þ¤ò¤â¤¿¤é¤·¤Æ¤¤¤ë ¡¢¤È¤¤¤¦¤³¤È¤Ï¤¤¤¨¤Þ¤¹¡£¡×

¤³¤ì¤ËÂФ·¤Æ¡¢Æ±¤¸¤è¤¦¤Ê¼ÁÌä¤È¤·¤ÆHelen Branswell»á¤«¤é¤Ä¤®¤Î¤è¤¦¤Ê¼ÁÌä

¡Öº£²ó¤Î¿··¿£È1£Î1¤ËÂФ·¤Æ¹³ÂΤϡ¢ËɸæÀ­¤¬¤¢¤ë¤Î¤Ç¤¹¤«?¡×

¥À¥Ë¥¨¥ë¡¦¥¸¥ã¡¼¥Ë¥¬¥ó(Daniel Jernigan)Çî»Î

¡Ö¤â¤Á¤í¤ó¡¢¤½¤ì¤Ï¡¢Æñ¤·¤¤ÌäÂê¤À¤È»×¤¤¤Þ¤¹¡£
¹³ÂΤÎËɸæ¸ú²Ì¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤è¤ê¿Ê¤ó¤À¸¦µæ¤¬É¬Íפʴ¶¤¸¤Ï¤·¤Þ¤¹¡£
¤·¤«¤·¡¢¸½ºß¤Î¸¡ºº¤«¤éȽÃǤ¹¤ë¸Â¤ê¡¢È¿±þÀ­¤Ø¤Î¾Úµò¤Ï¤¢¤ê¡¢¤½¤ì¤é¤Î¤³¤È¤«¤é¤ï¤ì¤ï¤ì¤¬¿äÏÀ¤¹¤ë¤È¤¹¤ì¤Ð¡¢°ìÄê¥ì¥Ù¥ë¤ÎËɸæ¸ú²Ì¤Ï¡¢¤¢¤ë¤È¤¤¤¨¤Þ¤¹¤¬¡¢ÃÇÄꤹ¤ë¤Þ¤Ç¤Ë¤Ï¤¤¤¿¤Ã¤Æ¤¤¤Þ¤»¤ó¡£¡×

¤µ¤é¤ËHelen Branswell»á¤«¤éÊä­¼ÁÌä

¡ÖÇî»Î¤Ï¤¿¤À¤¤¤Þ¡¢´¶À÷Ψ¤Ê¤É¤Î¿ô»ú¤ò¼¨¤µ¤ì¤Þ¤·¤¿¤¬¡¢ÉԻ׵Ĥˤª¤â¤¦¤Î¤Ï¡¢¤³¤ì¤Ï¡¢°äÅÁ»ÒÁÈ´¹¤¨¤Ë¤è¤ë ¹³¸¶¥·¥Õ¥È(antigenic shift)¤Ê¤Î¤Ç¤¹¤«?¤½¤ì¤È¤â¡¢¹³¸¶Ï¢Â³ÊÑ°Û(¹³¸¶¥É¥ê¥Õ¥È)(antigenic drift)¤Ë¤è¤ë¤â¤Î¤Ê¤Î¤Ç¤¹¤«?¡×

¥À¥Ë¥¨¥ë¡¦¥¸¥ã¡¼¥Ë¥¬¥ó(Daniel Jernigan)Çî»Î

¡Ö¤³¤ì¤Þ¤Ç¸«¤ë¸Â¤ê¡¢º£²ó¤Î¿··¿¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¥¦¥¤¥ë¥¹¤ËÂФ·¤Æ¡¢¿Í¸ý¤Î°ìÄê³ä¹ç¤Ï¡¢Ìȱ֤¬¤Ê¤¤¾õÂ֤Ǥ¹¡£
²áµî¤ÎH1N1¤¬µ¨ÀáÀ­¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¥¦¥¤¥ë¥¹¤È¤·¤Æ½Û´Ä¤·¤Æ¤­¤¿¤â¤Î¤Ç¡¢º£²ó¤Î¿··¿H1N1¤Ï¡¢¤½¤ì¤È¤³¤È¤Ê¤Ã¤¿¥µ¥Ö¥¿¥¤¥Ö¤Ç¤Ï¤Ê¤¤¤È¸«¤Æ¤¤¤Þ¤¹¤¬¡¢°ÊÁ°¤ÎH1N1¤Èº£²ó¤ÎH1N1¤È¤Î´Ö¤Îµ÷Î¥¤¬¤¢¤Þ¤ê¤Ë¤¢¤Ã¤¿¤¬¤¿¤á¤Ë¡¢º£²ó¤ÎH1N1¤Ë¤Ï¡¢ÀøºßŪ¤Ê¥¤¥ó¥Ñ¥¯¥È¤¬¤¢¤Ã¤¿¤Î¤Ç¤Ï¤Ê¤¤¤«¡¢¤È¡¢»×¤ï¤ì¤Þ¤¹¡£
º£²ó¤Î´¶À÷¤¬¡¢¥·¥Õ¥È¤«¥É¥ê¥Õ¥È¤«¤Ë¤Ä¤¤¤Æ¤Ï¡¢µÄÏÀÃæ¤Ç¤¹¡£¡×

¼¡¤Î°ìö¥ï¥¯¥Á¥ó¤ÎÏä˼Áµ¿¤ÎÏÃÂ꤬ķ¤ó¤À¤È¡¢ºÆ¤Ó¡¢Ï·Îð¼ÔÌȱÖÀâ¤Ë¤Ä¤¤¤Æ

Betsy McKay»á¤«¤é¼ÁÌä

¡Ö1957ǯ°ÊÁ°¤ÎH1N1¤Ø¤ÎÇøϪ¤Ë¤Ä¤¤¤Æ¤Ç¤¹¤¬¡¢¤³¤Î1957ǯ°ÊÁ°¤ÎH1N1¤¬º£²ó¤Î¥Ñ¥ó¥Ç¥ß¥Ã¥¯¤È´Ø·¸¤·¤Æ¤¤¤ë¤Î¤Ç¤·¤ç¤¦¤«?
¤½¤·¤Æ¡¢º£²ó¤Î¼ã¤¤À¤Âå¤Ø¤Î´¶À÷¤Ï¡¢¤É¤Î¤¯¤é¤¤¹­¤¬¤ë¤Î¤Ç¤·¤ç¤¦¤«?¡×

¥À¥Ë¥¨¥ë¡¦¥¸¥ã¡¼¥Ë¥¬¥ó(Daniel Jernigan)Çî»Î

¡Ö¸å¼Ô¤Î¼ÁÌ䤫¤éÅú¤¨¤ì¤Ð¡¢Øí´µ¼Ô¤Î18¥Ñ¡¼¥»¥ó¥È¤Ï10ºÐ¤«¤é18ºÐ¤Î¼ã¤¤À¤Âå¤Ç¤¹¡£
11¥Ñ¡¼¥»¥ó¥È¤Ï¡¢5ºÐ¤«¤é9ºÐ¤Î»Ò¶¡¤Ç¤¹¡£
Âç¿¿ô¤ÎÆþ±¡¤·¤Æ¤¤¤ë¿Í¤ÎǯÎðÉý¤Ï¡¢37¥Ñ¡¼¥»¥ó¥È¤¬¡¢19ºÐ¤«¤é49ºÐ¤Î´Ö¤Ç¤¹¡£
¤·¤«¤·¡¢¤Ê¤«¤Ë¤Ï¡¢50ºÐ¤«¡¢¤½¤ì°Ê¾å¤ÎǯÎð¤Î¿Í¤â13¥Ñ¡¼¥»¥ó¥ÈÄøÅÙ¡¢¤¤¤ë¤³¤È¤Ï¤¤¤Þ¤¹¡£
¤·¤«¤·¡¢³ØÀ¸¤Î´¶À÷Áý²ÃΨ¤Ï¡¢¤½¤ì¤éϷǯ¤Î´¶À÷¼Â¿ô¤ò¾å²ó¤Ã¤Æ¤¤¤Þ¤¹¡£

Âè°ì¤Î¼ÁÌä¤ËÌá¤ì¤Ð¡¢H1N1¤Ï¡¢Åö½é¡¢1918ǯ¤Ë¸½¤ì¤Æ¡¢¤½¤Î¸å¡¢Ëèǯ¤Îµ¨ÀáÀ­¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¥·¡¼¥º¥ó¤Ë¸½¤ì¡¢¤½¤Î´Ö¤ËÅö½é¤Î¥¦¥¤¥ë¥¹¤Ï¥É¥ê¥Õ¥È¤·¡¢1957ǯ¤Ë¤½¤Î»Ñ¤ò¸½¤·¤Þ¤·¤¿¡£
¤½¤·¤Æ¡¢¤½¤ÎH1N1¤Ï¡¢H2N2¤ÈÆþ¤ìÂؤï¤ê¤Þ¤·¤¿¡£
¤³¤Î1957ǯ¤Î»þÅÀ¤¬¤Þ¤µ¤Ë¡¢ ¤½¤ì¤Þ¤Ç¤Î²áµî¤ÎH1N1¤¬¡¢½ªßá¤ò·Þ¤¨¤¿»þÅÀ¤È¤¤¤¦¤ï¤±¤Ç¤¹¡£¡×

¤³¤³¤Ç¡¢¤µ¤é¤Ë¾¤Î¼ÁÌ䤬¤Ï¤¤¤Ã¤¿¤¢¤È¡¢Mike Stobbe»á¤«¤é¼ÁÌä

¡ÖCDC¤¬ °ìÄê¤ÎǯÎðÁؤ˺£²ó¤ÎH1N1¤ËÌȱ֤¬¤¢¤ë¤³¤È¤òǧ¤á¤¿¤È¤³¤È¤Ï¤ï¤«¤ê¤Þ¤·¤¿¡£
¤½¤ÎǯÎðÁؤȤϡ¢50ºÐ°Ê¾å¤È¤¤¤¦¤³¤È¤Ç¤·¤ç¤¦¤«?¡×

¥À¥Ë¥¨¥ë¡¦¥¸¥ã¡¼¥Ë¥¬¥ó(Daniel Jernigan)Çî»Î

¡ÖÀè¤Û¤É¤â¿½¤·¾å¤²¤Þ¤·¤¿¤¬¡¢º£Æü¤Î¸á¸å¤«ÌÀÆü¤Ë¤Ç¤ëMMWR(Morbidity and Mortality Weekly Report )¤Ë¡¢»ä¤è¤ê¤â¡¢¤½¤ÎÅÀ¤Ë¤Ä¤¤¤Æ¡¢ÍºÊۤ˸ì¤é¤ì¤Æ¤¤¤Þ¤¹¤Î¤Ç¡¢¤½¤Á¤é¤ò¤´»²¾È´ê¤¤¤Þ¤¹¡£¡×

Richard Knox»á¤Î¼ÁÌä

¡ÖÆóÅÀ¤Ë¤Ä¤¤¤Æ¼ÁÌ䤷¤Þ¤¹¡£
°ìÅÀ¤Ï¡¢Ìȱ֤ò»ý¤Ä¿Í¸ý¤¬¾¯¤Ê¤¤¤³¤È¤È¡¢¥¦¥¤¥ë¥¹¤Î¥¢¥¿¥Ã¥¯Î¨¤¬¡¢²ÈÄí¤â¥³¥ß¥å¥Ë¥Æ¥£¤â³Ø¹»¤â¡¢Ä̾ï¤Îµ¨ÀáÀ­¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¤Î¾ì¹ç¤Ï¡¢ÊѤï¤é¤Ê¤¤¤È¤¤¤¦¤³¤È¤È¤Î´Ø·¸¤¬¤è¤¯¤ï¤«¤é¤Ê¤¤¤Î¤Ç¤¹¤¬¡£
ÆóÅÀÌܤϡ¢Ä㤤ÌȱÖΨ¤¬¥¢¥¿¥Ã¥¯Î¨¤ò¹â¤á¤Æ¤¤¤ë¤Î¤«? ¡×

¥À¥Ë¥¨¥ë¡¦¥¸¥ã¡¼¥Ë¥¬¥ó(Daniel Jernigan)Çî»Î

¡Ö¥¢¥¿¥Ã¥¯Î¨¤Ï¡¢´¶À÷¤Î°ìÉô¤Î¤³¤È¤Ç¤¢¤ê¡¢´¶À÷¤Î¾É¾õ¤Î¿ÊŸ¤Ï¡¢¥¦¥¤¥ë¥¹¤ò¼õ¤±¤¿¥Û¥¹¥È¼¡Âè¤È¤¤¤¦¤³¤È¤Ë¤Ê¤ê¤Þ¤¹¡£
º£Ç¯¤Î12·îÃʳ¬¤Æ¡¬¤Îµ¨ÀáÀ­¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¤¬¥·¥Ó¥¢¤Ë¤Ê¤ë¤â¤Î¤È¤Îͽ¬¤Ï¤¢¤ê¤¨¤Þ¤¹¡×

Richard Knoxȇ

¡Ö¥¤¥ê¥Î¥¤½£¤ä¥¦¥£¥¹¥³¥ó¥·¥ó½£¤¬¡¢Â¾¤Î¥«¥ê¥Õ¥©¥ë¥Ë¥¢½£¤ä¥Ë¥å¡¼¥è¡¼¥¯½£¤Ê¤É¤È¤¯¤é¤Ù¤Æ¡¢Èô¤Ó¤Ì¤±¤Æ´¶À÷¤¬¤Ò¤É¤¤¤Î¤Ç¤¹¤¬¡¢¤½¤ÎÍýͳ¤Ï¤Ê¤Ë¤Ê¤Î¤Ç¤·¤ç¤¦?¡×

¥À¥Ë¥¨¥ë¡¦¥¸¥ã¡¼¥Ë¥¬¥ó(Daniel Jernigan)Çî»Î

¡Ö¤½¤ÎÅÀ¤Ï¡¢»ä¤É¤â¤âÄ´ººÃæ¤Ç¤¹¡£
¤½¤ì¤é¤Î½£¤Î¿Í¡¹¤¬ÇøϪ¤µ¤ì¤Æ¤¤¤ë¡¢¤Ê¤ó¤é¤«¤Î¥Õ¥¡¥¯¥¿¡¼¤«¥¤¥Ù¥ó¥È¤¬¤¢¤ë¤Î¤À¤È»×¤¤¤Þ¤¹¡£
¤½¤ì¤Ï¡¢É¬¤º¤·¤â¡¢¤½¤ÎÅÚÃÏÆÃÍ­¤Ê²¹Å٤伾ÅÙ¤äÃÏÍýŪ¾ò·ï¤¬È¿±Ç¤·¤¿¤â¤Î¤È¤Ï¸Â¤é¤Ê¤¤¤â¤Î¤È¿ä¬¤·¤Æ¤¤¤Þ¤¹¡£¡×

¤Ä¤®¤ËDonald McNeil»á¤¬¼ÁÌä

¡Ö·ìÀ¶¸¡ºº¤Ë¤Ä¤¤¤Æ¡¢¤â¤Ã¤È¾Ü¤·¤¯¶µ¤¨¤Æ¤¯¤À¤µ¤¤¡£¡×

¥À¥Ë¥¨¥ë¡¦¥¸¥ã¡¼¥Ë¥¬¥ó(Daniel Jernigan)Çî»Î

¡Ö¤³¤ì¤Ë¤Ä¤¤¤Æ¤âÌÀÆü¤ÎMMWR(Morbidity and Mortality Weekly Report )¤ò¸«¤Æ¤¯¤À¤µ¤¤¡¢¤³¤Î¤³¤È¤Ë¤Ä¤¤¤Æ¤âͺÊۤˤ«¤¤¤Æ¤¢¤ê¤Þ¤¹¤«¤é¡£
¤¿¤À¡¢¸À¤¨¤ë¤³¤È¤Ï¡¢·ìÀ¶¸¡ºº¤Ë¤è¤Ã¤Æ¡¢¤½¤Î·ì±Õ¤Î¿Í¤¬¡¢²áµî¤Ë¤É¤Î¤è¤¦¤Ê¥¦¥¤¥ë¥¹¤ËÇøϪ¤µ¤ì¤¿¤¬¤ï¤«¤ë¡¢¤È¤¤¤¦¤³¤È¤Ç¤¹¡£¡×

°Ê¾å¤À¤¬¡¢´Î¿´¤ÎMMWR(Morbidity and Mortality Weekly Report )
http://www.cdc.gov/mmwr/weekcvol.html
¤Îµ­»ö¤À¤¬¡¢¤Þ¤À¡¢ ¸½»þÅÀ¤Ç¤Ï¡¢¥ê¥ê¡¼¥¹¤µ¤ì¤Æ¤¤¤Ê¤¤¤è¤¦¤À ¡£

Äɵ­2009/05/22

¾åµ­¤Ç¤¤¤Ã¤Æ¤¤¤ëMMWR(Morbidity and Mortality Weekly Report )¤ÎÊó¹ð½ñ¤¬¤è¤¦¤ä¤¯È¯É½¤µ¤ì¤Þ¤·¤¿¡£

¡ÖSerum Antibody Response to a Novel Influenza A (H1N1) Virus After Vaccination with Seasonal Influenza Vaccine ¡×
¤Ç¤¹¡£

ÆâÍƤϲ¼µ­¤Î¤È¤ª¤ê¤Ç¤¹¡£

CDC¤Ç¤Ï¡¢ º£²ó¤Î¿··¿¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¥¦¥¤¥ë¥¹H1N1¤ËÂбþ¤¹¤ë¥ï¥¯¥Á¥ó¤ÎÀ½Â¤¤¬¿ô¥ö·î¤«¤«¤ë¸«Ä̤·¤Ç¤¢¤ë¤È¤³¤í¤«¤é¡¢¸½ºß¤Îµ¨ÀáÀ­¥¤¥ó¥Õ¥ë¥¨¥ó¥¶Íѥ說¥Á¥ó¤ÇÂåÍѤ·¤¦¤ë¥¦¥¤¥ë¥¹¤Ê¤Î¤«¤ò¸¡¾Ú¤¹¤ë¤¿¤á¤Ë¡¢¤³¤ì¤Þ¤Ç¤Î¥ï¥¯¥Á¥ó¸¦µæ¤Ç½¸¤á¤Æ¤­¤¿Êݸ·ìÀ¶¸«Ëܤò »È¤Ã¤Æ¡¢º£²ó¤Î¿·¤·¤¤H1N1¤ËÂФ·¤Æ¡¢¸òº¹È¿±þ¹³ÂΤΥì¥Ù¥ë¤ò¸¡¾Ú¤¹¤ë¤³¤È¤Ë¤·¤¿¡£

¤½¤ÎÊýË¡¤Ï¡¢¤Þ¤º¡¢Í½ËÉÀܼ路¤¿Ç¯Å٤˱þ¤¸¤Æ¡¢Âç¿Í¤È»Ò¶¡¤Î¥³¥Û¡¼¥È¤Ë¤ï¤±¤Æ¡¢¸¡¾Ú¤·¤¿¡¢
­¡2005ǯ¤«¤é2006ǯ¤Ë¤«¤±¤Æ¤ÎͽËÉÀܼï¤Ë¤ª¤¤¤Æ¡¢¤½¤ÎͽËÉÀܼï¤ÎÁ°¸å¤ÎÈæ³Ó
­¢2006ǯ¤«¤é2007ǯ¤Ë¤«¤±¤Æ¤ÎͽËÉÀܼï¤Ë¤ª¤¤¤Æ¡¢¤½¤ÎͽËÉÀܼï¤ÎÁ°¸å¤ÎÈæ³Ó
­£2007ǯ¤«¤é2008ǯ¤Ë¤«¤±¤Æ¤ÎͽËÉÀܼï¤Ë¤ª¤¤¤Æ¡¢¤½¤ÎͽËÉÀܼï¤ÎÁ°¸å¤ÎÈæ³Ó
­¤2008ǯ¤«¤é2009ǯ¤Ë¤«¤±¤Æ¤ÎͽËÉÀܼï¤Ë¤ª¤¤¤Æ¡¢¤½¤ÎͽËÉÀܼï¤ÎÁ°¸å¤ÎÈæ³Ó

¤³¤Î·ë²Ì¤ï¤«¤Ã¤¿¤³¤È¤Ï¡¢
­¡»Ò¶¡¤Î¥³¥Û¡¼¥È¤Ë¤ª¤¤¤Æ¤Ï¡¢¥ï¥¯¥Á¥óÀܼïÁ°¤Ï¡¢º£²ó¤Î¿·¤·¤¤H1N1¤ËÂФ·¤Æ¤Ï¡¢¤Ê¤ó¤é¡¢¸òº¹È¿±þ¹³ÂΤϡ¢¸«¤é¤ì¤Ê¤«¤Ã¤¿¡£
¥ï¥¯¥Á¥óÀܼïÁ°¤Ë¤ª¤¤¤Æ¤Ï¡¢À¸¥ï¥¯¥Á¥ó¡¢ÉԳ貽¥ï¥¯¥Á¥ó¤È¤â¡¢º£²ó¤Î¿·¤·¤¤H1N1¤ËÂФ·¤Æ¤Ï¡¢¤Ê¤ó¤é¡¢¸òº¹È¿±þ¹³ÂΤϡ¢¸«¤é¤ì¤Ê¤«¤Ã¤¿¡£
­¢Âç¿Í¤Î¥³¥Û¡¼¥È¤Ë¤ª¤¤¤Æ¤Ï¡¢18ºÐ¤«¤é64ºÐ¤Î´Ö¤ÎǯÎðÁؤˤª¤¤¤Æ¡¢¤½¤Î6¥Ñ¡¼¥»¥ó¥È¤«¤é9¥Ñ¡¼¥»¥ó¥È¤Ë¤Ä¤¤¤Æ¡¢¥ï¥¯¥Á¥óÀܼïÁ°¤Ë¡¢¸òº¹È¿±þ¹³ÂΤ¬¸¡½Ð¤µ¤ì¤¿¡£
60ºÐ°Ê¾å¤ÎǯÎðÁؤˤĤ¤¤Æ¤Ï¡¢¤½¤Î33¥Ñ¡¼¥»¥ó¥È¤Ë¤Ä¤¤¤Æ¡¢¸òº¹È¿±þ¹³ÂΤ¬¸¡½Ð¤µ¤ì¤¿¡£
µ¨ÀáÀ­¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¡¦¥ï¥¯¥Á¥ó¤Ë¤ª¤¤¤Æ¤Ï¡¢º£²ó¤Î¿·¤·¤¤H1N1¤ËÂФ·¤Æ¤Ï¡¢
18ºÐ¤«¤é64ºÐ¤ÎǯÎðÁؤˤª¤¤¤Æ¤Ï¡¢2Çܤθòº¹È¿±þ¹³ÂΤ¬¸¡½Ð¤µ¤ì¤¿¤Î¤ËÂФ·¤Æ¡¢
60ºÐ°Ê¾å¤ÎǯÎðÁؤˤª¤¤¤Æ¤Ï¡¢¤½¤ì¤¬¡¢20Çܤ«¤é90Çܤθòº¹È¿±þ¹³ÂΤ¬¸¡½Ð¤µ¤ì¤¿¡£
¤³¤ì¤é¤Î¥Ç¡¼¥¿¤«¤é¸«¤ë¤Ë¡¢ºÇ¶á¤Î2005ǯ¤«¤é2006ǯ¤Îµ¨ÀáÀ­¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¡¦¥ï¥¯¥Á¥ó¤ÎÀܼï¤Ç¤Ï¡¢º£²ó¤Î¿·¤·¤¤H1N1¤ËÂФ·¤Æ¤Ï¡¢Ëɸ湳ÂΤò³ÍÆÀ¤Ç¤­¤½¤¦¤â¤Ê¤¤¤è¤¦¤Ë¸«¤é¤ì¤¿¡£

¡¡

¤ªÃΤ餻:
ÆüËܤ«¤é¥·¥«¥´¤Î¥ª¥×¥·¥ç¥óÇäÇ㤬¤Ç¤­¤ë¤¿¤á¤Î¥Þ¥Ë¥å¥¢¥ë
¡Ö¥·¥«¥´¡¦¥ª¥×¥·¥ç¥óÇäÇãÀïά¥Þ¥Ë¥å¥¢¥ë¡×(A4ÈÇ273¥Ú¡¼¥¸¡¢5,900±ß)¤ò¤³¤Î¤¿¤Ó½ñ¤­¾å¤²¡¢È¯´©¤·¤Þ¤·¤¿¡£

ÆâÍÆ¡¦Ìܼ¡¤Î¤´³Îǧ¤ä¤ªµá¤á¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

¤ªÆÁÍѤʥÀ¥¦¥ó¥í¡¼¥ÉÈÇ-ÅŻҽñÀÒPDF¥Õ¥¡¥¤¥ë(273¥Ú¡¼¥¸¡¢3,980±ß)¤´´õ˾¤Î¾ì¹ç¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£


Check Page Rank of any web site pages instantly:


This free page rank checking tool is powered by Page Rank Checker service

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.